Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Chembiochem : a European Journal of Chemical Biology|November 14, 2018
Exploiting the Cellular Redox-Control System for Activatable Photodynamic TherapyNima Gharibi, Karishma Kailass, Andrew A Beharry
Journal of Medicinal Chemistry|June 14, 2022
Two-Photon Photodynamic Therapy Targeting Cancers with Low Carboxylesterase 2 Activity Guided by Ratiometric FluorescenceKarishma Kailass, Oleg Sadovski, Warren R Zipfel, et al.
ACS Medicinal Chemistry Letters|August 20, 2021
A Green-Absorbing, Red-Fluorescent Phenalenone-Based Photosensitizer as a Theranostic Agent for Photodynamic TherapyEsther G Kaye, Karishma Kailass, Oleg Sadovski, et al.
Chemical Communications (Cambridge, England)|September 6, 2022
Selective detection of carboxylesterase 2 activity in cancer cells using an activity-based chemiluminescent probeCagri Ozsan, Karishma Kailass, Elyse M Digby, et al.
ACS Sensors|April 27, 2026
Ratiometric Fluorescent Chemosensing for Predicting Response to Irinotecan-Based Therapies in Pancreatic Ductal AdenocarcinomaKarishma Kailass, Alexandra F Tassielli, Ruifan Dai, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Orthogonal resistance mechanisms of classical- and induced-proximity inhibitorsManuel L Merz, Karishma Kailass, Rajaiah Pergu, et al.
Journal of Medicinal Chemistry|January 24, 2024
Tight-Binding Small-Molecule Carboxylesterase 2 Inhibitors Reduce Intracellular Irinotecan ActivationKarishma Kailass, Dominick Casalena, Lina Jenane, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
Anti-CRISPR-mediated continuous directed evolution of CRISPR-Cas9 in human cellsAndrew L Sabol, Amanuella A Mengiste, Vedagopuram Sreekanth, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2026
Anti-CRISPR-mediated continuous directed evolution of CRISPR-Cas9 in human cellsAndrew L Sabol, Amanuella A Mengiste, Prashant Singh, et al.
Pageof 2